Virtual Library

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

Filter Results:

Show Only Available Presentations

  • +

    Resistance to TKIs

    • Type: Educational session
    • Presentations: 5
    • Moderators:T.S.K. Mok
    • Coordinates: 4/13/2018, 11:00 - 12:30, Room B
  • +

    Poster Display session (Friday)

    • Type: Poster Display session
    • Presentations: 197
    • Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
    • +

      Tumour biology and pathology

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      4P - Assessment of PD-L1 expression by immunohistochemistry in histological and cytological non-small cell lung carcinoma (NSCLC) in the era of immunotherapy: A national Irish study

      12:30 - 12:30  |  Presenter: A. Fabre

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      5P - Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Y. Saito

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      6P - Mechanisms of regulating PD-L1 expression in non-small cell lung cancer during EMT process

      12:30 - 12:30  |  Presenter: F. Li

      • Abstract

      Loading...

    • +

      7P - The regulation of FOXP3 expression by GLI-1 in non-small cell lung cancer cells and its influence on lung cancer cell stemness

      12:30 - 12:30  |  Presenter: H. Qi

      • Abstract

      Loading...

    • +

      8P - Noncanonical Wnt11, a tumor suppressive gene by antagonizing canonical Wnt signaling, represents a putative molecularly therapeutic target in lung cancer

      12:30 - 12:30  |  Presenter: X. Wang

      • Abstract

      Loading...

    • +

      9P - Mesenchymal stem cells’ microvesicles from primary and metastatic NSCLC niches differentially modulate lung cancer cells

      12:30 - 12:30  |  Presenter: O. Attar-Schneider

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      10P - The micro-environmental cross talk between mast cells and lung cancer cells through cell-to-cell contact

      12:30 - 12:30  |  Presenter: R. Shemesh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      11P - Glycolysis enzyme screenings identify non-glycolytic function of aldolase A that interacts and alters F-actin dynamics to promote lung cancer metastasis

      12:30 - 12:30  |  Presenter: Y. Chang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      12P - Cigarette smoke promotes proliferation of non-small cell lung cancer (NSCLC) via enhancing glucose uptake and glycolysis

      12:30 - 12:30  |  Presenter: I. Hsieh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      13P - The identification of binding targets for pro-metastatic protein NIFK in lung cancer

      12:30 - 12:30  |  Presenter: T.C. Lin

      • Abstract

      Loading...

    • +

      14P - MMP-2 1306 C/T promoter polymorphism and smoking: A possible role as risk factors in lung cancer

      12:30 - 12:30  |  Presenter: A. Daniele

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      15P - Comprehensive profiling of lincRNAs in lung adenocarcinoma of never smokers reveals their important roles in cancer development and prognosis

      12:30 - 12:30  |  Presenter: Y. Li

      • Abstract

      Loading...

    • +

      16P - Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression

      12:30 - 12:30  |  Presenter: C. Qinnan

      • Abstract

      Loading...

    • +

      17P - Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell progression by silencing of P21 expression

      12:30 - 12:30  |  Presenter: C. Zhenyao

      • Abstract

      Loading...

    • +

      18P - The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non-small cell lung cancer

      12:30 - 12:30  |  Presenter: W. Chenchen

      • Abstract

      Loading...

    • +

      19P - Single sample predictor of non-small cell lung cancer histology based on gene expression analysis of archival tissue

      12:30 - 12:30  |  Presenter: A. Karlsson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      20P - ArgSS1 expression in squamous cell carcinoma of the lung

      12:30 - 12:30  |  Presenter: E. Cathcart-Rake

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      21P - Influence of delayed and prolonged fixation on the evaluation of immunohistochemical staining on pulmonary resection specimen

      12:30 - 12:30  |  Presenter: M. Van Seijen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      22P - Clonal and subclonal occurrence of oncogenic mutations in lung adenocarcinoma

      12:30 - 12:30  |  Presenter: V. Tischler

      • Abstract

      Loading...

    • +

      23P - Genomic profiling of gene aberrations in 323 Chinese NSCLC patients

      12:30 - 12:30  |  Presenter: Y. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      24P - Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) inhibition with AZD1208 to prevent resistance to osimertinib in EGFR mutant NSCLC

      12:30 - 12:30  |  Presenter: J. Bracht

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      25P - A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: M. Ito

      • Abstract

      Loading...

    • +

      26P - Incidence of T790M mutations after progression on first Line EGFR TKIS in advanced NSCLC: Real time data from a tertiary cancer institute in North India

      12:30 - 12:30  |  Presenter: U. Batra

      • Abstract

      Loading...

    • +

      27P - ALK immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients

      12:30 - 12:30  |  Presenter: G. Metro

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      28P - The study of ALK rearrangement in advanced primary non-small cell lung cancer and associated metastatic lesions

      12:30 - 12:30  |  Presenter: C. Xu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      29P - Preliminary assessment of a targeted break-point NGS assay for ALK gene fusion detection in lung adenocarcinoma samples from Chilean patients

      12:30 - 12:30  |  Presenter: M. Freire

      • Abstract

      Loading...

    • +

      30P - Feasibility of anti-ROS1 SP384 for detection of ROS1 protein

      12:30 - 12:30  |  Presenter: I. Menzl

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      31P - Analysis of ROS1 rearrangement non-small cell lung cancer cell blocks from pleural effusion

      12:30 - 12:30  |  Presenter: W. Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      32P - Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non-small cell lung cancer

      12:30 - 12:30  |  Presenter: A. Alhanafy

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      33P - Expression of biomarkers IDH1, CEA, TPA and CYFRA21-1 in peripheral blood and tissue of non-small cell lung carcinoma patients detected by real-time PCR

      12:30 - 12:30  |  Presenter: A. Mishra

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      34P - Recommendations for EGFR mutation testing with a fast and fully automated sample-to-result system: How to optimize DNA input instead of using lung cancer tissue?

      12:30 - 12:30  |  Presenter: C. Chapusot

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Prevention, Early Detection, Epidemiology, Tobacco control

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      37P - Epidemiology and management of bronchopulmonary carcinoma in eastern Morocco of 738 cases

      12:30 - 12:30  |  Presenter: I. Alloubi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      38P - Survival of lung cancer: Bangladesh perspective

      12:30 - 12:30  |  Presenter: R. Parveen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      39P - Lung cancer in Morocco: Results of a retrospective study

      12:30 - 12:30  |  Presenter: A. Haimer

      • Abstract

      Loading...

    • +

      40P - Comparison of clinical characteristics and survival of lung cancer patients in a Canadian province and in the United States according to insurance status

      12:30 - 12:30  |  Presenter: A. Matutino

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      41P - Gender based variations in presentation and management of lung cancer at a south Asian tertiary referral centre

      12:30 - 12:30  |  Presenter: V. Vashistha

      • Abstract

      Loading...

    • +

      42P - Is there a delay in diagnosis of lung cancer in women?

      12:30 - 12:30  |  Presenter: Y. Tolwin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      43P - A network-based signature to predict the survival of non-smoking lung adenocarcinoma

      12:30 - 12:30  |  Presenter: Q. Mao

      • Abstract

      Loading...

    • +

      44P - A large population-based study on large cell neuroendocrine lung cancer: A SEER database analysis

      12:30 - 12:30  |  Presenter: X. Fu

      • Abstract

      Loading...

    • +

      48P - Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression

      12:30 - 12:30  |  Presenter: H. Park

      • Abstract

      Loading...

    • +

      49P - Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis

      12:30 - 12:30  |  Presenter: J.H. Chang

      • Abstract

      Loading...

    • +

      50P - The expression and significance of miR-146a and miR-146b in BALB/c mice pulmonary precancerous lesions induced by fine particulate matter

      12:30 - 12:30  |  Presenter: T. Hou

      • Abstract

      Loading...

    • +

      Translational research

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      53P - Lung cancer: Beyond EGFR and ALK dichotomy

      12:30 - 12:30  |  Presenter: C.T. Satheesh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      54P - Epidermal growth factor receptor expression (EGFR) in serum as a marker of treatment response and survival in advanced squamous cell lung cancer

      12:30 - 12:30  |  Presenter: A. Mohan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      56P - Plasma circulating ctDNA: Potential biomarker in non-small cell lung carcinoma and clinical significance

      12:30 - 12:30  |  Presenter: V. Goel

      • Abstract

      Loading...

    • +

      57P - Targeted sequencing of plasma-derived cfDNA in patients with metastatic NSCLC

      12:30 - 12:30  |  Presenter: R. Pasquale

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      58P - Co-treatment of trametinib (MEK inhibitor) with TPX-0005 (Src/FAK/JAK2 inhibitor) synergistic in KRAS mutant NSCLC cell lines and CDCP1 acts as a biomarker in KRAS mutant patients (p)

      12:30 - 12:30  |  Presenter: C. Codony-Servat

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      59P - Circulating microRNAs as novel predictive markers of afatinib efficacy in squamous cell lung cancer (SCC): An exploratory sub-analysis of the LUX-Lung 8 trial

      12:30 - 12:30  |  Presenter: Y. Gaston Math_

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      60P - Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial

      12:30 - 12:30  |  Presenter: Y. Gaston Math_

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      61P - mir-125b plays a tumor suppressor role in inflammation-related non-small cell lung cancer via repressing IGF-1 signal pathway

      12:30 - 12:30  |  Presenter: Y. Zhang

      • Abstract

      Loading...

    • +

      62P - MAP kinase signaling pathway in pulmonary adenocarcinomas: A study from India

      12:30 - 12:30  |  Presenter: V. Singh

      • Abstract

      Loading...

    • +

      63P - Prevalence and spectrum of germline mutations among patients with familial lung cancer

      12:30 - 12:30  |  Presenter: M. Kanwal

      • Abstract

      Loading...

    • +

      64P - Cisplatin-resistant phenotype: Characterization, adaptation to EGFR signaling and sensitivity to EGFR inhibitors in NSCLC cells

      12:30 - 12:30  |  Presenter: V. Pamidiboina

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      65P - Fatty acid synthase (FASN) inhibition effect on EGFR TKIs sensitive and resistant cells

      12:30 - 12:30  |  Presenter: S. Ruíz Martínez

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      66P - PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin

      12:30 - 12:30  |  Presenter: N. Karachaliou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      67P - The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: R. Grinberg

      • Abstract

      Loading...

    • +

      68P - In vivo study of a novel chemoablative, thermoresponsive hydrogel for intratumoural administration in a murine A549 xenograft model

      12:30 - 12:30  |  Presenter: S.M. Rossi

      • Abstract

      Loading...

    • +

      69P - The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy

      12:30 - 12:30  |  Presenter: T. Tsakiridis

      • Abstract

      Loading...

    • +

      70P - Immunological efficacy of anti-tumor dendritic cell vaccine application in patients with non-small cell lung cancer

      12:30 - 12:30  |  Presenter: O. Gorbach

      • Abstract

      Loading...

    • +

      Imaging and staging

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      73P - PET and neck US for the detection of cervical lymphadenopathy in patients with lung cancer and mediastinal lymphadenopathy

      12:30 - 12:30  |  Presenter: M. Ahmed

      • Abstract

      Loading...

    • +

      74P - Spatial concordance of tumor proliferation and accelerated repopulation from pathologic images to 18F-FLT PET images: A basic study guided for PET-based radiotherapy dose painting

      12:30 - 12:30  |  Presenter: C.M. Li

      • Abstract

      Loading...

    • +

      76P - Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR

      12:30 - 12:30  |  Presenter: D. Vuong

      • Abstract

      Loading...

    • +

      77P - Is there an incremental benefit with 68 Ga DOTA PET/CT in staging of broncho-pulmonary carcinoid tumors?

      12:30 - 12:30  |  Presenter: G. Karimundackal

      • Abstract

      Loading...

    • +

      SCLC

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      79P - Small cell lung cancer in the young: Characteristics, timeliness and outcome data

      12:30 - 12:30  |  Presenter: S. Jiang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      80P - Understanding the patient perspective of small cell lung cancer (SCLC)

      12:30 - 12:30  |  Presenter: A. Rydén

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      81P - The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: A. Vedadi

      • Abstract

      Loading...

    • +

      82P - Chemotherapy versus combined chemoradiotherapy: Survival patterns among patients with extensive disease small cell lung cancer

      12:30 - 12:30  |  Presenter: I. Uthman

      • Abstract

      Loading...

    • +

      83P - Radiotherapy improves the survival of patients with extensive disease small cell lung cancer: A propensity matched analysis of surveillance, epidemiology and end results database

      12:30 - 12:30  |  Presenter: R. Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      84P - Patterns of care for patients with small cell lung cancer: A survey of German radiation oncology institutions on recommendations for prophylactic cranial irradiation

      12:30 - 12:30  |  Presenter: C. Eze

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      85P - Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer (ES-SCLC): A tertiary cancer centre experience

      12:30 - 12:30  |  Presenter: A. Srivastava

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      86P - Prophylactic cranial irradiation in SCLC: A survey of German radiation oncology institutions on recommendations for brain imaging

      12:30 - 12:30  |  Presenter: C. Eze

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      87P - Assessment of the prognostic utility of the enumeration of circulating tumour cells at the end of treatment and disease relapse in small cell lung cancer patients

      12:30 - 12:30  |  Presenter: A.J. Vickers

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      88P - Feasibility of outpatient dinutuximab (D) and irinotecan (I) for second-line treatment of relapsed or refractory small cell lung cancer (RR SCLC): Part 1 of an open-label, randomized, phase 2/3 study

      12:30 - 12:30  |  Presenter: M.J. Edelman

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      89P - The role of palliative care in extensive stage lung cancer

      12:30 - 12:30  |  Presenter: Y. Ahmed

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      90P - Study of intestinal flora differences between small cell lung cancer (SCLC) patients and healthy people

      12:30 - 12:30  |  Presenter: L. Zhang

      • Abstract

      Loading...

    • +

      Early stage NSCLC

      12:30 - 12:30

      • Abstract

      No abstract available for this presentation

    • +

      92P - Expression of TNFRII in serum is correlated with the significant risk of subcentimeter lung adenocarcinoma

      12:30 - 12:30  |  Presenter: Y. Zhang

      • Abstract

      Loading...

    • +

      93P - DNA damage repair protein expression and EGFR gene status in NSCLC

      12:30 - 12:30  |  Presenter: J. Wang

      • Abstract

      Loading...

    • +

      94P - Lung cancer recurrence in patients with pre-operative circulating tumor DNA and elevated tumor markers

      12:30 - 12:30  |  Presenter: S. Isaksson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      95P - Intubated versus non-intubated general anesthesia for minimally invasive video-assisted thoracic surgery (VATS) in octogenarians

      12:30 - 12:30  |  Presenter: N. Ilic

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      96P - The role of bronchial stump reinforcement by flap in prevention of broncho-pleural fistula after major lung resections

      12:30 - 12:30  |  Presenter: F. Caushi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      97P - Multistep prediction of cardio-pulmonary morbidity after lung cancer surgery

      12:30 - 12:50  |  Presenter: N. Lukavetskyy

      • Abstract

      Loading...

    • +

      98P - Trends in and impact of hospital-acquired adverse events in patients with lung cancer undergoing lung resection

      12:50 - 12:50  |  Presenter: A. Gupta

      • Abstract

      Loading...

    • +

      100P - Prognostic factors in surgically resected N2 small cell lung cancer: Significance of the subcarinal node

      12:50 - 12:50  |  Presenter: R. Qiao

      • Abstract

      Loading...

    • +

      101P - Overtreatment in early lung cancer: Survival is independent of pathological confirmation

      12:50 - 12:50  |  Presenter: F. Zehentmayr

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      102P - Stereotactic lung radiotherapy for early-stage NSCLC: An institution's experience

      12:50 - 12:50  |  Presenter: N. Ferreira

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      103P - Stereotactic body radiotherapy followed by radiofrequency ablation for inoperable stage Ib non-small cell lung cancer

      12:50 - 12:50  |  Presenter: H. Ding

      • Abstract

      Loading...

    • +

      104P - Adjuvant chemotherapy may improve prognosis in surgically resected stage I NSCLC with lymphovascular invasion

      12:50 - 12:50  |  Presenter: S. Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      105P - Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected non-small cell lung cancer

      12:50 - 12:50  |  Presenter: R. Dokuni

      • Abstract

      Loading...

    • +

      106P - The value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma

      12:50 - 12:50  |  Presenter: S. Cao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      107P - Meta-analysis on defining optimal follow up of patients with early stage NSCLC after definitive therapy

      12:50 - 12:50  |  Presenter: D. Wankhede

      • Abstract

      Loading...

    • +

      108TiP - A multi-center, prospective, randomized controlled clinical trial: Comparison between wedge resection and segmentectomy in the surgical treatment of ground glass opacity-dominant stage IA non-small cell lung cancer

      12:50 - 12:50  |  Presenter: L. Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Locally advanced NSCLC

      12:50 - 12:50

      • Abstract

      No abstract available for this presentation

    • +

      113P - Exosomal miRNAs in peripheral blood as novel diagnostic biomarkers of radioresistant lung adenocarcinoma

      12:50 - 12:50  |  Presenter: C. Zhu

      • Abstract

      Loading...

    • +

      114P - Evaluation of pulmonary function parameters after moderate hypofractionated image-guided thoracic irradiation in locally advanced node-positive non-small cell lung cancer patients with very limited lung function

      12:50 - 12:50  |  Presenter: F. Manapov

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      115P - Heart and pulmonary artery radiation doses in non-small cell lung cancer

      12:50 - 12:50  |  Presenter: K. Thippu Jayaprakash

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      116P - Comparison of conformity and homogeneity index values of VMAT and non-VMAT techniques used in lung cancer radiotherapy

      12:50 - 12:50  |  Presenter: A. Ozen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      117P - Feasibility of moderate hypofractionated image-guided thoracic irradiation for locally advanced node-positive non-small cell lung cancer patients with very limited lung function

      12:50 - 12:50  |  Presenter: F. Manapov

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      118P - A comparative study of sequential chemoradiation vs concurrent chemoradiation vs concurrent chemoradiation followed by consolidation chemotherapy in unresectable NSCLC

      12:50 - 12:50  |  Presenter: A. Datta

      • Abstract

      Loading...

    • +

      119P - Cisplatin/etoposide or paclitaxel/carboplatin with concurrent radiation therapy in stage IIIB non-small cell lung cancer: A one-year phase II trial at a low resource setting

      12:50 - 12:50  |  Presenter: M. Shuayb

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      120P - Optimal chemotherapy regimen for concurrent chemo-radiotherapy of locally advanced unresectable stage III non-small cell lung cancer (NCSLC)

      12:50 - 12:50  |  Presenter: N. Jokhadze

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      121P - Primary surgery followed by chemotherapy versus definitive concurrent chemoradiotherapy in locally advanced non-small cell lung cancer

      12:50 - 12:50  |  Presenter: I.Z. Kiladze

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      122P - Pathological response rates after induction radio-chemotherapy in stage III NSCLC

      12:50 - 12:50  |  Presenter: F. Casas

      • Abstract

      Loading...

    • +

      124P - Cardiac events in stage III non-small cell lung cancer (NSCLC): An attention shift to cardio-oncology collaboration

      12:50 - 12:50  |  Presenter: J. Degens

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      125P - Brain metastases in patients with stage N2 non-small cell lung cancer

      12:50 - 12:50  |  Presenter: C. Lowrie

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      126TiP - SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC): A multicenter single-arm phase II trial

      12:50 - 12:50  |  Presenter: S.I. Rothschild

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      127TiP - Phase I study of neo-adjuvant Stereotactic Body Radiotherapy (SBRT) in operable patients with borderline resectable locally advanced NSCLC (LA-NSCLC) (LINNEARRE I STUDY: NCT02433574)

      12:50 - 12:50  |  Presenter: T. Tsakiridis

      • Abstract

      Loading...

    • +

      Advanced NSCLC

      12:50 - 12:50

      • Abstract

      No abstract available for this presentation

    • +

      145P - Impact of next-generation sequencing on survival in lung cancer

      12:50 - 12:50  |  Presenter: S. Geva

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      146P - The clinical impact of comprehensive cfDNA genomic testing in lung cancer

      12:50 - 12:50  |  Presenter: S. Geva

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      147P - Clinical testing of ctDNA from NSCLC patients using A 17-gene liquid biopsy mutation panel

      12:50 - 12:50  |  Presenter: D.A. Eberhard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      148P - Method comparison for detection of epidermal growth factor receptor (EGFR) T790M mutation in matched biopsied tumour sections and plasma samples

      12:50 - 12:50  |  Presenter: J. Longshore

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      149P - Real-world outcomes with first-line afatinib in EGFR mutant NSCLC adenocarcinoma: A single centre experience exploring effects of dose-reduction

      12:50 - 12:50  |  Presenter: N. Tokaca

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      150P - Correlation between erlotinib-induced rash and efficacy in first-line therapy of patients with advanced non-small cell lung cancer (NSCLC) expressing epidermal growth factor receptor (EGFR)-mutation: A prospective, multi-center, open-label, single-arm, phase II study

      12:50 - 12:50  |  Presenter: M. Gottfried

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      151P - Maintenance therapy using tyrosine kinase inhibitor (erlotinib) or pemetrexed in metastatic/locally advanced in EGFR mutation-negative lung cancer: Comparison of results

      12:50 - 12:50  |  Presenter: K. Gupta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      152P - Impaired liver function was associated with PFS of EGFR TKI treatment

      12:50 - 12:50  |  Presenter: Q. Zhu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      153P - EGFR T790M co-exists with sensitive mutations in the same cell group in lung adenocarcinoma patients

      12:50 - 12:50  |  Presenter: X. Shi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      154P - CNS response to osimertinib in patients with EGFR mutated lung adenocarcinoma: Real world data

      12:50 - 12:50  |  Presenter: R. Devjak

      • Abstract

      Loading...

    • +

      155P - Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models

      12:50 - 12:50  |  Presenter: F. Morgillo

      • Abstract

      Loading...

    • +

      156P - ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain

      12:50 - 12:50  |  Presenter: D. Vicente Baz

      • Abstract

      Loading...

    • +

      157P - Second-line afatinib for patients with locally advanced or metastatic NSCLC harbouring common EGFR mutations: A phase IV study

      12:50 - 12:50  |  Presenter: S. Thongprasert

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      158P - Afatinib in patients with EGFR mutation-positive (EGFRm+) NSCLC harbouring uncommon mutations: Overview of clinical data

      12:50 - 12:50  |  Presenter: A. Märten

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      159P - Clinical activity of afatinib in a cohort of patients with lung adenocarcinoma harbouring uncommon EGFR mutations: A Spanish retrospective multicentre study

      12:50 - 12:50  |  Presenter: M.T. Moran Bueno

      • Abstract

      Loading...

    • +

      160P - Real world study of lung squamous cell carcinoma patients with EGFR mutation treated with EGFR-TKI

      12:50 - 12:50  |  Presenter: L. Miao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      161P - The survival of advanced non-small cell lung cancer with epidermal growth factor receptor in Thailand: A single instituition review

      12:50 - 12:50  |  Presenter: A. Supavavej

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      162P - Responses to EGFR TKIs and ALK TKIs in advanced NSCLC patients harboring concomitant EGFR and ALK alterations

      12:50 - 12:50  |  Presenter: S. Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      163P - The influence of 2nd and 3rd generation TKI in EGFR mt+ and ALK+ patients on OS and PFS: Results of the NOWEL network

      12:50 - 12:50  |  Presenter: J. Roeper

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      164P - Feasibility of liquid biopsy using plasma and platelets for detection of ALK rearrangements in non-small cell lung cancer

      12:50 - 12:50  |  Presenter: C. Park

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      165P - Analysis of our experience of ROS-1 patients in advanced NSCLC

      12:50 - 12:50  |  Presenter: N. Pande

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      166P - Evidence-based conclusions and inclinations of pemetrexed, taxane and bevacizumab in advanced lung cancer

      12:50 - 12:50  |  Presenter: S. Shaheen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      167P - Efficacy of pemetrexed-based chemotherapy in advanced lung adenocarcinoma patients with ROS-1 rearrangement

      12:50 - 12:50  |  Presenter: B. Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      168P - Pemetrexed dosing regimens in patients with advanced NSCLC

      12:50 - 12:50  |  Presenter: S. Visser

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      169P - Nephrotoxicity of pemetrexed maintenance in patients with advanced NSCLC: Two cohort studies

      12:50 - 12:50  |  Presenter: S. Visser

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      170P - A phase II trial of nab-paclitaxel and gemcitabine in patients with non-small cell lung cancer previously treated with platinum based chemotherapy

      12:50 - 12:50  |  Presenter: Y. Hatakeyama

      • Abstract

      Loading...

    • +

      171P - A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer

      12:50 - 12:50  |  Presenter: Y. Kono

      • Abstract

      Loading...

    • +

      172P - Safety and efficacy phase 2 study of nab-paclitaxel maintenance treatment after nab-paclitaxel plus carboplatin in stage IIIB/IV non-small cell lung cancer

      12:50 - 12:50  |  Presenter: A. Nakao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      173P - Apatinib plus S-1 showes encouraging response in advanced non-small-cell lung canceras as laterline chemotherapy

      12:50 - 12:50  |  Presenter: Z. wu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      174P - Aprepitant, palonosetron and dexamethasone proved effective to prevent chemotherapy-related nausea and vomiting in lung cancer

      12:50 - 12:50  |  Presenter: Y. Zhang

      • Abstract

      Loading...

    • +

      175P - A prospective, randomized, double-blind study of pre-chemotherapy hydration with or without mannitol to prevent renal toxicity in non-small cell lung cancer (NSCLC) patients receiving cisplatin-gemcitabine chemotherapy

      12:50 - 12:50  |  Presenter: N. Thavornpattanpong

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      176P - PrediCare: A new diagnostic tool predicting imminent disease progression in advanced NSCLC patients by machine-learning integration of three serum biomarkers

      12:50 - 12:50  |  Presenter: Y. Kogan

      • Abstract

      Loading...

    • +

      177P - Clinicopathologic characteristics in large cell neuroendocrine carcinomas of the lung (LCNCL): The experience of one center

      12:50 - 12:50  |  Presenter: M. Vaslamatzis

      • Abstract

      Loading...

    • +

      178P - Smo inhibitor LDE225 reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) cells

      12:50 - 12:50  |  Presenter: Y. Yu

      • Abstract

      Loading...

    • +

      179P - The cytoplasmic LKB1 promotes the growth of human lung adenocarcinoma by enhancing autophagy

      12:50 - 12:50  |  Presenter: M.J. Liu

      • Abstract

      Loading...

    • +

      180P - Significant progress in palliative treatment of NSCLC over the last decades: Correlation of treatment milestones with survival in unselected patients

      12:50 - 12:50  |  Presenter: S.I. Rothschild

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      181P - Real-world comparative effectiveness of treatment sequences in metastatic non-small cell lung cancer with squamous histology

      12:50 - 12:50  |  Presenter: H. Yang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      182P - Real world anti-PD-L1 treatment (tx) outcomes in a multinational European non-small cell lung cancer (NSCLC) cohort with focus on toxicity (tox) and brain metastases (BM): Preliminary data from an EORTC young investigators lung cancer group collaborative analysis

      12:50 - 12:50  |  Presenter: R. Tassi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      183P - Progression of central nervous system metastases in advanced non-small cell lung cancer patients effectively treated with first-generation EGFR-TKI

      12:50 - 12:50  |  Presenter: M. Yu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      184P - Clinico-radiological pattern of response to nivolumab in stage IV NSCL: A real life experience over two years

      12:50 - 12:50  |  Presenter: M. Perna

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      185P - Retrospective study of tumour responses and toxicities associated with anti-PD1 antibody therapy in elderly cancer patients(>75yo) in comparison to patients ≤75yo with metastatic non-small cell lung cancer

      12:50 - 12:50  |  Presenter: L.C. CHONG

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      186P - Thyroid toxicity as an immune-related adverse event in patients with non-small cell lung cancer during treatment with immune checkpoint inhibitors

      12:50 - 12:50  |  Presenter: K. Syrigos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      187P - Nivolumab-related immune-related adverse events in advanced NSCLC predict therapeutic objective response

      12:50 - 12:50  |  Presenter: J. Rogado

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      188P - Treatment switching–adjusted overall survival (OS) in KEYNOTE-024: First-line pembrolizumab versus chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

      12:50 - 12:50  |  Presenter: M. Reck

      • Abstract

      Loading...

    • +

      189P - Are pretreatment neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and advanced lung cancer inflamation index (ALI) levels useful in predicting the outcomes of patients with advanced non-small cell lung cancer?

      12:50 - 12:50  |  Presenter: B. Komurcuoglu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      190P - Are neutrophil-to-lymphocyte ratio (NLR) and neutrophil count percentage (NCP) predictors of nivolumab outcome and toxicity in NSCLC?

      12:50 - 12:50  |  Presenter: J. Rogado

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      192P - KRAS as predictive biomarker of response to checkpoint inhibitors in NSCLC

      12:50 - 12:50  |  Presenter: A. Addeo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      193TiP - Phase 3 study of epacadostat plus pembrolizumab with or without platinum-based chemotherapy vs pembrolizumab plus chemotherapy for first-line metastatic non-small cell lung cancer (mNSCLC): ECHO-306/KEYNOTE-715

      12:50 - 12:50  |  Presenter: M. Garassino

      • Abstract

      Loading...

    • +

      194TiP - eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients

      12:50 - 12:50  |  Presenter: L. Horn

      • Abstract

      Loading...

    • +

      195TiP - A phase 3, randomized, double-blind study of epacadostat plus pembrolizumab vs pembrolizumab as first-line therapy for metastatic non-small cell lung cancer (mNSCLC) expressing high PD-L1 levels (ECHO-305/KEYNOTE-654)

      12:50 - 12:50  |  Presenter: L. Paz-Ares

      • Abstract

      Loading...

    • +

      196TiP - CheckMate 384: A phase 3b/4 dose-frequency optimization trial of nivolumab in advanced or metastatic NSCLC

      12:50 - 12:50  |  Presenter: E. Garon

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      197TiP - A phase 1/2 trial of selinexor combined with docetaxel for previously treated, advanced KRAS mutant non-small cell lung cancer

      12:50 - 12:50  |  Presenter: A. Gupta

      • Abstract

      Loading...

    • +

      198TiP - Afatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study

      12:50 - 12:50  |  Presenter: N. Karachaliou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      199TiP - TTFields concurrent with standard of care for stage 4 non-small cell lung cancer (NSCLC) following platinum failure: Phase 3 LUNAR study

      12:50 - 12:50  |  Presenter: U. Weinberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Metastases to and from the lung

      12:50 - 12:50

      • Abstract

      No abstract available for this presentation

    • +

      201P - Isolation of circulating tumor cells and potential heterogeneity analysis in advanced non-small cell lung cancer

      12:50 - 12:50  |  Presenter: H. Zhang

      • Abstract

      Loading...

    • +

      202P - The clone evolutionary landscape and genomic characteristics of osteosarcoma and lung metastasis

      12:50 - 12:50  |  Presenter: J. Lai

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      203P - Combined pulmonary metastasectomy and chemotherapy in patients with colorectal lung metastases and concurrent extrapulmonary disease

      12:50 - 12:50  |  Presenter: M. Faisal

      • Abstract

      Loading...

    • +

      204P - Clinicopathological features, treatment patterns and outcomes of pulmonary metastasectomy

      12:50 - 12:50  |  Presenter: P. Shivanna

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      205P - RNA-seq analysis of lung adenocarcinomas reveals different circular RNA expression profiles between non-metastatic and metastatic patients

      12:50 - 12:50  |  Presenter: D. Wu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      206P - Isolated splenic metastasis from non-small cell lung cancer: Study of an extremely rare clinical entity with review of all cases reported in the literature

      12:50 - 12:50  |  Presenter: N. Mitsimponas

      • Abstract

      Loading...

    • +

      207P - A comparison of outcomes of stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases

      12:50 - 12:50  |  Presenter: Y.H. Lee

      • Abstract

      Loading...

    • +

      208P - Metastatic non-small cell lung carcinoma: About 420 cases

      12:50 - 12:50  |  Presenter: H. Loubna

      • Abstract

      Loading...

    • +

      209P - The management of brain disease (BD) in ALK-rearranged non-small cell lung cancer (ALK NSCLC): Can systemic treatment delay the initiation of local treatments? Experience of the Ramón y Cajal University Hospital (RyCUH, Madrid)

      12:50 - 12:50  |  Presenter: R. Martin Huertas

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      210P - Brain oligometastases in NSCLC: Therapeutic effect and prognostic factors of WBRT combined with intracarotid infusion of elemene

      12:50 - 12:50  |  Presenter: Y. XU

      • Abstract

      Loading...

    • +

      211P - First analysis of a real-world study to explore the character and treatment outcome of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) on non-small cell lung cancer (NSCLC) with brain metastases (BM)

      12:50 - 12:50  |  Presenter: H. Zhang

      • Abstract

      Loading...

    • +

      212P - Clinical experience and predictive factors of response to whole brain radiotherapy in metastatic lung cancer: A single institute experience

      12:50 - 12:50  |  Presenter: V.V. Pareek

      • Abstract

      Loading...

    • +

      Mesothelioma

      12:50 - 12:50

      • Abstract

      No abstract available for this presentation

    • +

      217P - Impact of VEGF and CD74 expression on response and survival of malignant pleural mesothelioma patients treated with gemcitabine and cisplatin: A phase II retrospective study

      12:50 - 12:50  |  Presenter: D.A. Soliman

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      219P - Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated after first line chemotherapy (CT)

      12:50 - 12:50  |  Presenter: S. Cedres Perez

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      220P - Effects of pifithrin-μ on the growth of acidity-tolerant malignant mesothelioma cells and epithelial-mesenchymal transition

      12:50 - 12:50  |  Presenter: S. Lee

      • Abstract

      Loading...

    • +

      221P - Treatment experience of pleural malignant mesothelioma in a tertiary referral center in Mexico

      12:50 - 12:50  |  Presenter: A.M. Gutierrez

      • Abstract

      Loading...

    • +

      222P - Women: The other face of malignant pleural mesothelioma

      12:50 - 12:50  |  Presenter: M.E. Brandão

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Miscellaneous

      12:50 - 12:50

      • Abstract

      No abstract available for this presentation

    • +

      223P - Sarcomatoid lung carcinoma: An uncommon and deadly entity

      12:50 - 12:50  |  Presenter: A. Sharma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      224P - The role of surgery in the treatment of lung neuroendocrine tumors (NETs) based on a 3-year experience of a thoracic department

      12:50 - 12:50  |  Presenter: B. von Amann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      225P - Surgical experience of advanced bronchopulmonary carcinoids: An analysis from a tertiary care hospital of North India

      12:50 - 12:50  |  Presenter: N. Kumar

      • Abstract

      Loading...

    • +

      226P - Accuracy of mutation analysis in small tissues from transbronchial lung biopsy with radial probe endobronchial ultrasound

      12:50 - 12:50  |  Presenter: M.K. Lee

      • Abstract

      Loading...

    • +

      227P - Stereotactic body radiotherapy with helical tomotherapy for lung tumors: A single-center experience

      12:50 - 12:50  |  Presenter: V. Figlia

      • Abstract

      Loading...

    • +

      228P - Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment

      12:50 - 12:50  |  Presenter: S. Yang

      • Abstract

      Loading...

    • +

      229P - Clinical and laboratory markers of prognosis in lung cancer patients with hypercalcemia

      12:50 - 12:50  |  Presenter: K. Syrigos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      230P - Experience with the implant of vascular access devices by medical oncologists in a non-surgical setting

      12:50 - 12:50  |  Presenter: A. Revuelta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      231P_PR - Impact of the continuity of nursing care delivered by a pivot nurse in oncology on improving satisfaction and quality of life of patients with advanced lung cancer

      12:50 - 12:50  |  Presenter: E. Kassouf

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      232TiP - Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized, double-blind, placebo-controlled, international phase 3 SPINET Study

      12:50 - 12:50  |  Presenter: X.M. Truong Thanh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Industry Satellite Symposium 6

    • Type: Industry Satellite Symposium
    • Presentations: 0
    • Coordinates: 4/13/2018, 13:00 - 14:00, Room A
  • +

    Industry Satellite Symposium 7

    • Type: Industry Satellite Symposium
    • Presentations: 0
    • Coordinates: 4/13/2018, 13:00 - 14:00, Room C
  • +

    Keynote lecture

    • Type: Keynote Lecture
    • Presentations: 1
    • Moderators:M. Reck
    • Coordinates: 4/13/2018, 14:10 - 14:40, Room B
  • +

    Epidemiology and outcomes

    • Type: Poster Discussion session
    • Presentations: 11
    • Moderators:A. Dingemans
    • Coordinates: 4/13/2018, 14:45 - 15:45, Room W
    • +